Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 3856Neoplasms 2988Prostatic Neoplasms 1751Colorectal Neoplasms 1426Lung Neoplasms 1328Motor Activity 802Head and Neck Neoplasms 683Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 648Carcinoma, Non-Small-Cell Lung 629Carcinoma, Hepatocellular 628Rectal Neoplasms 569Stomach Neoplasms 544Brain Neoplasms 483Ovarian Neoplasms 438Anxiety Disorders 419Pain 418Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 339Melanoma 322Multiple Myeloma 321Lymphoma 305Depression 305Endometrial Neoplasms 289Liver Neoplasms 279

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Disease Attributes × Clear all
NCT04831307 2021-12-03

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

British Columbia Cancer Agency

Phase NA Unknown
10 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT04462926 2020-09-17

PSMA-PROSTAPET

Azienda Ospedaliero-Universitaria di Modena

Phase NA Unknown
100 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡